Background: Interventions to reduce medicines discontinuity at transitions during and reinforced after discharge are effective. However, few studies have linked hospital-based counseling with onward referral for community pharmacy-based follow-up to support patients' medicines use. Objective: To determine the effects of targeted hospital pharmacist counseling on discharge or targeted community pharmacy medicines reviews post-discharge on patients' knowledge of newly started medication. Methods: The study was a controlled trial of targeted medicines discharge counseling provided by hospital pharmacists or follow-up post-discharge medicines review provided by community pharmacists compared with usual care (nurse counseling). Outcomes measured using a structured telephone survey conducted at two and four weeks after patients were discharged from hospital. Results: Patients who received hospital pharmacist counseling were significantly more likely to report being told the purpose of their new medicine and how to take it versus those receiving usual care. Fewer than half of the patients who were allocated to receive a community pharmacy medicines review received one. Conclusions: Patient knowledge of medicines newly prescribed in the hospital was increased by targeted counseling of hospital pharmacists. The findings suggest the need to improve the consistency of the information covered when providing counseling, perhaps by the implementation of a counseling checklist for use by all disciplines of staff involved in patient counseling. The potential of community pharmacy follow-up medicines review is currently undermined by several barriers to uptake.
Introduction
Patients who are discharged from the hospital often have new medicines prescribed and medicines-related problems at care transitions are a global problem for which solutions have long been sought. Discontinuity of care, multiple changes to medication, and inadequate patient information can lead to adverse drug events. A systematic review of interventions to reduce medicines discontinuity at transitions showed that patient education and counseling during and reinforced after discharge are effective. 1 However few studies have linked hospital-based counseling with onward referral for community pharmacybased follow-up to support patients' medicines use. Furthermore it may not be possible to provide pharmacist counseling in hospitals for all patients due to limitations on pharmacist resources and typically much counseling is provided by nurses. Little attention has been paid in previous research to how best to target pharmacist and nurse discharge medicines counseling. The current study set out to investigate the effects of targeted hospital pharmacist counseling and, where patients cannot be counseled by a hospital pharmacist on discharge, whether there might be a benefit in referral to their community pharmacist. In the UK, community pharmacies are funded by the National Health Service to provide postdischarge medicines use reviews (MURs), thus offering the opportunity to study the effects of a more systematic linkage between hospital and handover to community.
Study objective
To determine the effects of targeted hospital pharmacist counseling on discharge or targeted community pharmacy medicines reviews postdischarge on patients' knowledge of newly started medication.
Methods
A telephone survey at 2 and 4 weeks following discharge was selected as the study method. A postal survey was considered but not chosen due to concerns about potentially low response rates. The questions, which were piloted prior to the study, covered knowledge of: what the new medicine was for, how to take it, side-effects, tests and monitoring. Likert-type scales were used to assess patients' knowledge of their new medicines. Open questions were included to inquire about patients' opinions on the discharge medicines service provided and the information they had received.
Patients from 11 medical wards in one NHS hospital in England who were discharged on one or more new medicines during a five month period in 2013 were invited to take part. Patients who did not manage their own medication or those who did not have capacity to provide informed consent were excluded. New medication was identified by ward pharmacists from prescriptions and medical notes or from the discharge letter (local policy required that changes to medication during admission should be documented in the discharge letter).
Patients were allocated sequentially to one of four groups; 1) Hospital pharmacist counseling 2) Usual care (nurse or doctor counseling) þ community pharmacy MUR 3) Hospital pharmacist counseling þ community pharmacy MUR 4) Usual care
Usual care: the hospital's written policy on discharge medicines stated that the prescriber was responsible during the inpatient stay for communicating with the patient about any newly started, stopped or changed medication and ensuring medicines information needs were met, referring as necessary to a pharmacist. On discharge it was the nurse's responsibility to give the patient their copy of the discharge letter containing the list of discharge medicines, and to ensure the patient understood how to take their medicines and arrangements for obtaining a further supply. Pharmacy staff were responsible for counseling patients referred by their medical and nursing colleagues and patients identified during their stay as having specific counseling needs e.g. if the cause of their admission was related to poor adherence or they were prescribed certain 'high-risk' medicines.
Following granting of ethical and research governance approvals patients were approached by the lead researcher and given a participant information sheet with the details of the research together with a consent form and a MUR information leaflet explaining how their local community pharmacy could help after discharge. The documents were left with the patient for a minimum of 24 h to enable the patient to read and ask questions prior to deciding whether to take part and, for those participating, to sign the consent form. The consent form requested permission to share discharge medicines information with the patient's community pharmacy and GP (by providing them with a copy of the discharge letter). Patients who agreed to take part were asked for their contact details, including telephone number, and also whether they had a 'regular' community pharmacy. If they did, they were asked for the name and address of the pharmacy and that pharmacy was informed of the patients discharge and request for a MUR. If the patient was unable to provide details of a community pharmacy or the community pharmacy contacted was not accredited to carry out MURs they were allocated to groups 1 or 4.
Participating patients were telephoned by the researcher approximately two weeks after discharge and asked to complete the survey. Patients allocated to groups 2 or 3 were also asked to arrange and attend a MUR at the community pharmacy which usually dispensed their prescriptions, and to give the researcher a suggested date for calling back for the follow-up survey. If they were unable to arrange a MUR or no longer wanted to have one they were reallocated to groups 1 or 4. Patients in groups 2 and 3 were contacted again to complete the telephone survey after their MUR. The actual follow-up period for completing the telephone survey was dependent on the group to which patients were allocated. Patients could ask to be called back at a more convenient time and some did so.
The Fisher's exact test was used to compare the hospital pharmacist intervention groups with usual care. This was an exploratory study, and there was no information on which to base an estimate of possible effect size. As such, a formal sample size calculation was not undertaken.
Results and discussion
One hundred and one patients were recruited to the study and allocated sequentially to the four groups. The numbers in each group were not evenly distributed (Table 1) for the following reasons: i) hospital policy required patients newly prescribed high-risk medicines to be allocated to group 1 or 3; ii) the patient was unable to obtain a MUR (due to their not having a regular community pharmacy; their regular community pharmacy not being accredited to provide MURs; the patient being unable to travel to the pharmacy for an MUR; or at follow-up the patient no longer wanted to have a MUR) so were reallocated to groups 1 or 4. At follow-up, 18 patients were reallocated from groups 2 and 3.
Eighty four patients (83.2% of those recruited) completed the study. Of the seventeen lost to follow-up; eight withdrew; four died; two had provided incorrect contact details; two were transferred to rehabilitation (not managing their own medicines); and one had their new medication stopped prior to discharge.
Age, gender and number of new medicines were similar across the groups ( Due to the small number of patients completing the study in groups 2 and 3 (Table 1) , and following statistical advice, data were combined for the hospital pharmacist counseling in groups 1 and 3 (A) and compared to standard discharge counseling by a health care professional and/or MUR in groups 2 and 4 (B) ( Table 2 ). The four patient responses in group 3 after having a MUR were excluded due to the limitations of such a small sample size.
Patients reported that 93.8% of medicines in group A were provided with an explanation of how to take them compared to 51.4% in group B (P ! 0.05). Similarly 82.5% of medicines in group A were provided with an explanation of their purpose compared to 52.7% in group B (P ! 0.05). There was no statistically significant difference between groups A and B in the receipt of an explanation for how long it would take for the medication to act or what should be done if Counseling patients in the intervention groups significantly improved patients' knowledge of their medicines compared with usual care. Providing counseling has been shown to improve medication adherence and decrease readmission rates. 2 The recall of information will vary and the possible effect of this on the study results is not known. Patients in groups 2 and 3 had to arrange a MUR with their community pharmacy and would state a period of time of when they would be able to visit their pharmacy and when it would be convenient for the researcher to call them back. This meant that the period of time between the two telephone survey calls was longer. The information patients retain may also be linked to its perceived importance. Berry et al, (1997) 3 found that interactions with medication was ranked lower in importance by patients than by health professionals. This may partly explain the lower percentages of patients in both groups A and B agreeing (18.8% vs. 8.1%) when asked if an explanation was given about whether the medicine interferes with other medicines.
The medicines counseling provided by staff prior to, or upon discharge was generally seen positively by patients. Cooper & Garrett (2014) 4 studied inpatients' experiences and preferences of receiving medicines information and education. In that study over one-third of patients indicated that they would have liked more time to talk about their medications either in hospital or following discharge, of these 19% said they would have preferred a hospital pharmacist and 14% a community pharmacist. Some patients in the current study chose not to have a MUR with their community pharmacists but we do not know their reasons for this decision.
A recent systematic review concluded that intervention by community pharmacists postdischarge reduces medicines-related problems. 5 Despite this potential post-discharge MURs were under-utilized in the current study, received by fewer than half of the patients for whom it was recommended in study group allocation. A common reason for this was that patients who had their medication delivered to their home and thus did not usually visit their community pharmacy could not be allocated to receive a MUR. The usual method of MUR delivery is face-toface in the pharmacy, with telephone delivery currently only possible if the community pharmacist requests prior permission on an individual patient basis. Possible strategies to address the study findings include providing telephone MURs to improve access, identifying patients' MUR access and preferences while they are in hospital and targeting hospital pharmacist counseling more effectively, and providing feedback to service commissioners about how discharge medicines information services can be enhanced. An international review of regional and national initiatives relating to medicines at care transitions identified the importance of local implementation strategies in ensuring regional and national initiatives and policies work effectively. 6 This study has provided insights into how local policies can be refined.
Study limitations
The study had a number of limitations. The study hospital did not have a standard operating procedure (SOP) for specific medicines information items to be provided at discharge and it is therefore not possible to determine why items were omitted (possible reasons might be time constraints or that certain items are not usually covered by some staff). The results are also potentially limited by patient recall and the point of hospital discharge being a potentially stressful time when patients are waiting to be allowed to go home and therefore not ideal for information provision.
Conclusion
The results of this exploratory study indicate that patient knowledge of medicines newly prescribed in hospital is increased by targeted counseling by hospital pharmacists. The findings also suggest the need to improve the consistency of the information covered when providing counseling, perhaps by the implementation of a counseling checklist for use by all disciplines of staff involved in patient counseling. The potential of community pharmacy follow-up medicines reviews is currently undermined by several barriers including difficulties in access and patient reluctance to participate in a community pharmacy medicines review.
